Device Trial Radar · NCT00526058
(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol
Last checked: Nov 20, 2026Latest source record: Sep 14, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- B. Braun Medical Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 6, 2007
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 25 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to demonstrate that the performance of the modified Plasmat® Futura H.E.L.P. Apheresis System is non-inferior to the current FDA approved Plasmat® Secura H.E.L.P Apheresis System for use under the approved indication of the acute reduction of LDL-cholesterol from the plasma in populations for whom diet has been ineffective and maximum drug therapy has either been ineffective or not tolerated.
Conditions
- Hypercholesterolemia
Interventions
Secura then FuturaDevice
Randomized to 6 bi-monthly H.E.L.P. therapy treatments with the Plasmat® Secura apheresis system and then cross over to receive 6 bi-monthly treatments with the Plasmat® Futura apheresis system.
Futura then SecuraDevice
Randomized to 6 bi-monthly H.E L.P. therapy treatments with the Plasmat® Futura apheresis system and then cross over to receive 6 bi-monthly treatments with the Plasmat® Secura apheresis system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Pre- and Post-treatment Reductions of Low-density Lipoprotein Cholesterol (LDL-C) Levels Between the Approved H.E.L.P. System and the Modified H.E.L.P. System.Time frame: Blood samples for LDL-cholesterol determination will be obtained before and after each treatment from week 0 to week 24..
1 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Hartford Hospital
Hartford, Connecticut
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.